short term tirzepatide Compound tirzepatide short term use Short-term

Retatrutide targets three distinct receptor pathways (GLP-1, GIP, and glucagon) to suppress appetite, enhance fat metabolism, and promote significant weight loss averaging 24% over 48 weeks

KlepperJDiefenbachSKohlschtterAVoitT

Why GI Side Effects Happen Tirzepatide's mechanism of action explains why gastrointestinal symptoms are common

Prescribers who have expertise in obesity medicine While any licensed physician can prescribe GLP-1s, the nuances of safe and effective treatment are best handled by specialists in obesity medicine, primary care, endocrinology, or related fields

International journal of obesity (2005)